OptimizeRx Secures Exclusive Multi-Year Partnerships to Expand Point-of-Care Network

Reuters12-17
OptimizeRx Secures Exclusive Multi-Year Partnerships to Expand Point-of-Care Network

OptimizeRx Corporation has announced four new partner agreements that significantly expand its in-workflow point-of-care (POC) network and increase its National Provider Identifier (NPI) reach by 37%. Among these agreements is an exclusive, multi-year partnership with a high-demand e-prescribing (eRx) platform that was previously only available through a competitor. The company also secured multi-year renewals with two top-performing electronic health record (EHR) and eRx partners, with one of these agreements establishing exclusivity. Additionally, OptimizeRx has entered a new partnership that extends its reach into the point-of-discharge setting and broadens access to healthcare providers through an expanded network of EHR platforms. These partnerships reinforce OptimizeRx's leadership in the POC marketing landscape and position the company for sustained growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OptimizeRx Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9603157-en) on December 17, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment